Close

Indian state plans non-generic drugs procurement for government hospitals

Related stories

New Syngene biologics manufacturing facility to be operational for US and European customers from mid-year

At DCAT 2024 global bio/pharmaceutical manufacturing forum, Syngene International,...

ST Pharm breaks ground on 2nd oligonucleotide manufacturing plant

ST Pharm said it has taken its first step...

Elevating Biopharmaceutical Projects With The Right CDMO

In the biopharma industry, selecting the right contract development...

Biovian announces over €50 million investment in manufacturing facility in Turku, Finland

Biovian, a leading contract development and manufacturing organization (CDMO)...

New PAT – Based Strategy Stops Membrane Fouling In SP – TFF

A recent article published in the Journal of Membrane...

Indian state of Uttar Pradesh is planning to procure non-generic drugs directly from the manufacturing companies for usage in government hospitals in the state.

The state government is formulating a new drug policy that will allow the state health department to procure these drugs for government hospitals, unlike earlier the department used to procure only generic drugs manufactured by companies selected in the drug tender process at the state level.

Principal Secretary of Health and Family Welfare Sanjay Agarwal was quoted by expressindia.com as saying that the idea behind procurement of non-generic drugs is to provide the best quality drugs for chronic diseases in government hospitals.

“The proposal was approved by state’s Health Minister Ahmad Hasan, who wanted that the best quality drugs should also reach the poor people,” said Agarwal.

The state government has allocated a budget of INR45 crore ($8.13m) for procurement of 22 non-generic drugs listed by the department, which will used for ailments like diabetes, cardiac disease, blood pressure as well as some essential anti-biotic drugs, reports the website.

“The companies will enter into a contract with the department wherein they will have to certify that they would not sell these drugs to any other party at a cost lower than the price they are supplying the drugs to UP,” he added.

The non-generic drugs, to be procured by the department, will cost about half the cost of drugs available in the market, according to Agarwal.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories